Opportunities in RNA Targeting Small Molecule Drug Discovery are driven by advances in RNA biology, structural analysis, and ...
Researchers have developed a groundbreaking microscopy method that enables detailed three-dimensional (3D) RNA analysis at cellular resolution in whole intact mouse brains. The new method, called ...
Key opportunities lie in next-generation sequencing methods, with hospitals as major end-users and North America as a ...
La Jolla Labs was founded to make modern RNA biology and advanced computational techniques directly useful to patients whose ...
A new research paper featured as the cover of Volume 17, Issue 12 of Aging-US was published on December 22, 2025, titled “A ...
STORM Therapeutics Ltd. (STORM), the clinical stage company pioneering cellular reprogramming through RNA modifications to treat disease, today announced a strategic collaboration with Alida ...
STORM Therapeutics has entered a new collaboration with US‑based AlidaBio to accelerate the development of cancer therapies that target RNA modifications.
Years of experiments and databases filled with RNA-seq results belie the simple reality that, until fairly recently, it was impossible to analyze RNA directly. The RNA-seq studies performed with ...
Morning Overview on MSN
Frozen mammoth discovery shatters what scientists knew about ancient RNA
When scientists sliced into a block of Siberian permafrost and pulled out a woolly mammoth nicknamed Yuka, they expected to ...
Below is Validea's guru fundamental report for AVIDITY BIOSCIENCES INC (RNA). Of the 22 guru strategies we follow, RNA rates highest using our Quantitative Momentum Investor model based on the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback